ABCC8 and pulmonary arterial hypertension: The International PH Expert Panel employed a semi‐quantitative scoring system developed through the NIH Clinical Genome Resource to classify the relative strength of evidence supporting gene‐disease relationships for PAH based on genetic and experimental data, ABCC8 was categorized as having moderate evidence of clinical relevance to PAH [87].